BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38407967)

  • 1.
    Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
    Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of cancer and the benign call rate of afirma gene classifier in
    Endo M; Sipos JA; Ringel MD; Porter K; Nagaraja HN; Phay JE; Shirley LA; Long C; Wright CL; Roll K; Nabhan FA
    Cancer Med; 2021 Feb; 10(3):1084-1090. PubMed ID: 33449450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules.
    Chin PD; Zhu CY; Sajed DP; Fishbein GA; Yeh MW; Leung AM; Livhits MJ
    Endocr Pathol; 2020 Dec; 31(4):377-384. PubMed ID: 32671653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
    Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
    Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules.
    Larcher de Almeida AM; Delfim RLC; Vidal APA; Chaves MCDCM; Santiago ACL; Gianotti MF; Gonçalves MDDC; Vaisman M; de Carvalho DP; Teixeira PFDS
    Thyroid; 2021 Jun; 31(6):922-932. PubMed ID: 33143569
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Hu TX; Nguyen DT; Patel M; Beckett K; Douek M; Masamed R; Rhyu J; Kim J; Tseng CH; Yeh MW; Livhits MJ
    Thyroid; 2022 Aug; 32(8):905-916. PubMed ID: 35611970
    [No Abstract]   [Full Text] [Related]  

  • 7. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
    Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
    BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
    Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
    Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size.
    Dublin JC; Papazian M; Zan E; Oweity T; Sun W; Jacobson A; Patel K; Brandler TC; Givi B
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):53-60. PubMed ID: 34734965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of Cytologically Indeterminate Molecularly Benign Nodules Treated With Surgery.
    Endo M; Porter K; Long C; Azaryan I; Phay JE; Ringel MD; Sipos JA; Nabhan F
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e3971-80. PubMed ID: 32772084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.
    Stewardson P; Eszlinger M; Wu J; Khalil M; Box A; Perizzolo M; Punjwani Z; Ziehr B; Sanyal R; Demetrick DJ; Paschke R
    Thyroid; 2023 Dec; 33(12):1423-1433. PubMed ID: 37742115
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
    Zhu CY; Donangelo I; Gupta D; Nguyen DT; Ochoa JE; Yeh MW; Livhits MJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1240-e1247. PubMed ID: 33394039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country.
    Sanabria A
    Thyroid; 2020 Jul; 30(7):985-991. PubMed ID: 31950887
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid Nodules with Indeterminate Cytology: Utility of the American Thyroid Association Sonographic Patterns for Cancer Risk Stratification.
    Valderrabano P; McGettigan MJ; Lam CA; Khazai L; Thompson ZJ; Chung CH; Centeno BA; McIver B
    Thyroid; 2018 Aug; 28(8):1004-1012. PubMed ID: 29848195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
    Wu H; Zhang B; Cai G; Li J; Gu X
    PLoS One; 2019; 14(7):e0219383. PubMed ID: 31295281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules.
    Grani G; Lamartina L; Ascoli V; Bosco D; Nardi F; D'Ambrosio F; Rubini A; Giacomelli L; Biffoni M; Filetti S; Durante C; Cantisani V
    Endocrine; 2017 Aug; 57(2):256-261. PubMed ID: 27804016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
    Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
    J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and
    Hernandez-Prera JC; Valderrabano P; Creed JH; de la Iglesia JV; Slebos RJC; Centeno BA; Tarasova V; Hallanger-Johnson J; Veloski C; Otto KJ; Wenig BM; Yoder SJ; Lam CA; Park DS; Anderson AR; Raghunand N; Berglund A; Caudell J; Gerke TA; Chung CH
    Thyroid; 2021 Jan; 31(1):36-49. PubMed ID: 32689909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.